JCCC 2026 Issue 3
Table of Contents
Radiology
MD, CCFP, FCFP, FRCPC
Lecanemab (Leqembi®), approved by Health Canada in October 2025, represents Canada’s first disease-modifying therapy for Alzheimer’s disease.
Infectious Diseases
MBBCh, MPH, FIMC
As antibiotic development lags, AI-driven discovery, soil-derived compounds like teixobactin, and phage therapy offer renewed hope.
Medical Narratives
MSc, MD, CCFP, FCFP
When I checked my day schedule, I saw his name and had a deep sigh.
MD, CCFP, BSc.N
In this episode, Dr. Malak offers an overview of cancer screening in primary care.